Antiarrhythmic effect mediated by κ-opioid receptor is associated with Cx43 stabilization

Critical Care Medicine

Volumn 38, Issue 12, 2010, Pages 2365-2376

  Zhang, Quan Yu ^a,b   Wang, Wei ^a   Shi, Quan Xing ^a   Li, Yu Long ^a   Huang, Jing Hui ^a   Yao, Yuan ^a   Li, Juan ^a   Zhang, Shu Miao ^a   Fan, Rong ^a   Zhou, Jing Jun ^a   Guo, Hai Tao ^a   Wang, Yue Min ^a   Yin, Wen ^c   Pei, Jian Ming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

arrhythmia; cardiac gap junction connexins; Connexin43; ischemia reperfusion; myocardial ischemia; opioids

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; ANTIARRHYTHMIC AGENT; CONNEXIN 43; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; KAPPA OPIATE RECEPTOR ANTAGONIST; MESSENGER RNA; NOR BNI; UNCLASSIFIED DRUG;

ADRENERGIC STIMULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIARRHYTHMIC ACTIVITY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; ELECTROCARDIOGRAM; GENE EXPRESSION; HEART ARRHYTHMIA; HEART LEFT VENTRICLE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LEFT CORONARY ARTERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN STABILITY; PROTEIN STRUCTURE; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; TISSUE SECTION; UPREGULATION; WESTERN BLOTTING;

EID: 78650306313     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181fa0437     Document Type: Article

References (49)

1. Drinitsina SV, Azizova OA, Piriazev AP, et al: Correlations between electrophysiological myocardial remodeling and parameters of free radical oxidation in patients with various forms of ischemic heart disease. Ter Arkh 2006; 78:27-35
2. Sato T, Ohkusa T, Honjo H, et al: Altered expression of connexin43 contributes to the arrhythmogenic substrate during the development of heart failure in cardiomyopathic hamster. Am J Physiol Heart Circ Physiol 2008; 294:H1164-H1173
3. Lascano EC, Negroni JAL: Gap junctions in preconditioning against arrhythmias. Car-diovasc Res 2007; 74:341-342
4. De Groot JR, Coronel R: Acute ischemia-induced gap junctional uncoupling and ar-rhythmogenesis. Cardiovasc Res 2004; 62: 323-334
5. Schultz J, Rose E, Yao Z, et al: Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol Heart Circ Physiol 1995; 268:H2157-H2161
6. Genade S, Moolman JA, Lochner A: Opioid receptor stimulation acts as mediator of protection in ischaemic preconditioning. Cardiovasc J South Afr 2000; 11:8-16
7. Wu S, Li HY, Wong TM: Cardioprotection of preconditioning by metabolic inhibition in rat ventricular myocyte: involvement of K-opioid receptor. Circ Res 1999; 84: 1388-1395
8. 2+]i in myocytes. Am J Physiol 1997; 272: C560-C564
9. Wang GY, Wu S, Pei JM, et al: K- but not 8-opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats. Am J Physiol Heart Circ Physiol 2001; 280:H384-H391
10. Jin-Cheng L, Wen Y, Zhao Y, et al: Antiarrhythmic effects of kappa-opioid receptor and its changes in ischemia and reperfusion. Arch Med Res 2008; 39:483-488
11. Aitchison KA, Baxter GF, Awan MM, et al: Opposing effects on infarction of 8- and K-opioid receptor activation in the isolated rat heart: implications for ischemic preconditioning. Basic Res Cardiol 2000; 95:1-11
12. Wong TM, Lee AY, Tai KK: Effects of drugs interacting with opioid receptors during normal perfusion or ischemia and reperfusion in the isolated rat heart-An attempt to identify cardiac opioid receptor subtype(s) involved in arrhythmogenesis. J Mol Cell Cardiol 1990; 22:1167-1175
13. Pugsley MK, Penz WP, Walker MJ, et al: Cardiovascular actions of the K-agonist, U-50488H, in the absence and presence of opioid receptor blockade. Br J Pharmacol 1992; 105:521-526
14. Yu X, Zhang W, Bian J, et al: Pro- and antiarrhythmic effects of a kappa]-opioid receptor agonist: A model for the biphasic action of a local hormone in the heart. Clin Exp Pharmacol Physiol 1999; 26:842-844
15. Wong TM, Wu S: Roles of kappa opioid receptors in cardioprotection against ischemia-The signaling mechanisms. Acta Physiol Sinica 2003; 55:115-120
16. Yu XC, Li HY, Wang HX, et al: U50488H inhibits effects of norepinephrine in rat car-diomyocytes cross talk between opioid and pj -adrenergic receptors. J Mol Cell Cardiol 1998; 30:405-413
17. Yu XC, Wang HX, Pei JM, et al: Antiarrhythmic effect of K-opioid receptor stimulation in the perfused rat heart: Involvement of a cAMP-dependent pathway. J Mol Cell Cardiol 1999; 31:1809-1819
18. Wang GY, Zhou JJ, Shan J, et al: Protein kinase C-e is a trigger of delayed cardiopro-tection of K-opioid receptor stimulation in the rat heart. J Pharmacol Exp Ther 2001; 299:603-610
19. ATP channel triggers opioid-induced delayed cardioprotection in the rat. Circ Res 2002; 91:186-188
20. Zhou JJ, Pei JM, Wang GY, et al: Inducible heat shock protein 70 mediates delayed cardioprotection of U50488H pretreatment in rat ventricular myocytes. Am J Physiol 2001; 281:H40-H47
21. Ho JC, Wu S, Kam KW, et al: Effects of pharmacological preconditioning with U50488H on calcium homeostasis in rat ventricular myocytes subjected to metabolic inhibition and anoxia. Br J Pharmacol 2002; 137:739-748
22. Curtis M, Walker M: Quantification of arrhythmias using scoring systems: An examination of seven scores in an in vivo model of regional myocardial ischemia. Cardiovasc Res 1988; 22:656-665
23. + loss and arrhythmias in rat hearts: Effect of glibenclamide, a sulfony. Circ Res 1990; 66:478-485
24. Beardslee MA, Laing JG, Beyer EC, et al: Rapid turnover of connexin43 in the adult rat heart. Circ Res 1998; 83:629-662
25. Kwong KF, Schuessler RB, Green KG, et al: Differential expression of gap junction proteins in the canine sinus node. Circ Res 1998; 82:604-612
26. Tai KK, Bian CF, Wong TM: Kappa-opioid receptor stimulation increases intracellular free calcium in isolated rat ventricular myocytes. Life Sci 1992; 51:909-913
27. 2+ transient and hypertrophy induced by isoprenaline in neonatal rat ventricular myocytes-Role of CaMKII delta. Eur J Pharmacol 2008; 595:52-57
28. Lin JH, Weigel H, Cotrina ML, et al: Gap-junction-mediated propagation and amplification of cell injury. Nat Neurosci 1998; 1:494-500
29. i in rabbit ventricular myocytes during metabolic inhibition. J Mol Cell Cardiol 2001; 33:2145-2155
30. Zhang L, Rogers TJ: Kappa-opioid regulation of thymocyte IL-7 receptor and C-C chemo-kine receptor 2 expression. J Immunol 2000; 164:5088-5093
31. Belkowski SM, Alicea C, Eisenstein TK, et al: Inhibition of interleukin-1 and tumor necrosis factor-alpha synthesis following treatment of macrophages with the kappa opioid agonist U50,488. J Pharmacol Exp Ther 1995; 273:1491-1496
32. Thimm J, Mechler A, Lin H, et al: Calcium dependent open-closed conformations and interfacial energy maps of reconstituted hemichannels. J Biol Chem 2005; 280: 10646-10654
33. 2+ dynamics in cardiomyocytes at the border zone of myocardial infarcts. Cell Commun Adhes 2001; 8:335-338
34. Daleau P, Boudriau S, Michaud M, et al: Preconditioning in the absence or presence of sustained ischemia modulates myocardial Cx43 protein levels and gap junction distribution. Can J Physiol Pharmacol 2001; 79:371-378
35. Lin JH, Yang J, Liu S, et al: Connexin mediates gap junction-independent resistance to cell injury. J Neurosci 2003; 23:430-441
36. Yu XC, Wang HX, Pei JM, et al: Antiarrhythmic effect of K-opioid receptor stimulation in the perfused rat heart: involvement of a cAMP-dependent pathway. J Mol Cell Cardiol 1999; 31:1809-1819
37. Pei JM, Yu XC, Fung ML, et al: Impaired Gs and adenylyl cyclase cause fj -adrenoceptor desensitization in chronically hypoxic rat hearts. Am J Physiol (Cell Physiol) 2000; 279:C1455-C1463
38. 2+ and electrical alternans in cardiac myocytes: Role of CaMKII and repolarizing currents. Am J Physiol Heart Circ Physiol 2007; 292: H2854-H2866
39. Boengler K, Dodoni G, Rodriguez-Sinovas A, et al: Connexin 43 in cardiomyocyte mitochondria and its increase by ischemic preconditioning. Cardiovasc Res 2005; 67: 234-244
40. Sundset R, Cooper M, Mikalsen SO, et al: Isch-emic preconditioning protects against gap junctional uncoupling in cardiac myofibro-blasts. Cell Commun Adhes 2004; 11:51-66
41. Cinca J, Warren M, Carreñ o A, et al: Changes in myocardial electrical impedance induced by coronary artery occlusion in pigs with and without preconditioning: Correlation with local ST segment potential and ventricular arrhythmias. Circulation 1997; 96:3079-3086
42. Remme CA, Schumacher CA, De Jong JWJ: KATP channel opening during ischemia: Effects on myocardial noradrenaline release and ventricular arrhythmias. J Cardiovasc Pharmacol 2001; 38:406-416
43. Jain SK, Schuessler RB, Saffitz JE, et al: Mechanisms of delayed electrical uncoupling induced by ischemic preconditioning. Circ Res 2003; 92:1138-1144
44. Rakotovao A, Tanguy S, Toufektsian MC, et al: Selenium status as determinant of con-nexin-43 dephosphorylation in ex vivo isch-emic/reperfused rat myocardium. J Trace Elem Med Biol 2005; 19:43-47
45. Ando M, Katare RG, Kakinuma Y, et al: Efferent vagal nerve stimulation protects heart against ischemia-induced arrhythmias by preserving connexin43 protein. Circulation 2005; 112:164-170
46. Zhang JM, Li DQ, Yu SL, et al: Effect of candesartan on connexin 40 remodelling reduced by rapid pacing in rabbit atrium. Chin J Cardiac Pacing Cardiac Electrophysiol 2005; 19:385-387
47. Beardslee MA, Lerner DL, Tadros PN, et al: Dephosphorylation and intracellular redistribution of ventricular connexin43 during electrical uncoupling induced by ischemia. Circ Res 2000; 87:656-662
48. Zhang Y, Yue P, Xiao J, et al: Integration between M3 muscarinic acetylcholine receptor and connexin 43 as antiarrhythmic targets in rat ventricular myocardium. Yao Xue Xue Bao 2006; 41:395-400
49. Yue P, Zhang Y, Du Z, et al: Ischemia impairs the association between connexin 43 and M3 subtype of acetylcholine muscarinic receptor (M3-mAChR) in ventricular myocytes. Cell Physiol Biochem 2006; 17:129-136